Moderna Inc applied for U.S. emergency authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns, the...
from NDTV News - Latest https://ift.tt/2KYkESx
Monday, November 30, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment